MED — MEDIFAST INC
—
NYSE ·
Consumer Staples ·
Food Products ·
CIK 910329 ·
Last close
$12.19
Market Cap
$136.32M
52W High
$13.63
52W Low
$9.22
ADV30
127,005
Next earnings
2026-10-26
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 72,048,000 | 50,040,000 | -19,358,000 | -17,511,000 | 239,763,000 | 58,372,000 | 59,486,000 |
| Jun 2026 | 76,384,000 | 53,396,000 | -4,327,000 | -3,100,000 | 260,401,000 | 71,910,000 | 64,024,000 |
| Mar 2026 | 76,044,000 | 51,756,000 | -3,295,000 | -2,122,000 | 252,046,000 | 71,529,000 | 54,365,000 |
| Dec 2025 | 75,096,000 | 52,140,000 | -7,803,000 | -18,119,000 | 247,973,000 | 89,303,000 | 49,053,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-26,000
Investing CF
$-40,138,000
Financing CF
$-994,000
CapEx
$-3,843,000
Dividends Paid
$-170,000
Buybacks
$-824,000
EPS Diluted TTM
$-3.69
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$135,538,000
Inventory
$21,202,000
Receivables
—
ST Investments
$114,162,000
EBIT TTM
$-34,783,000
Pretax Income TTM
$-29,149,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$299,572,000
EBITDA
$-22,026,000
Free Cash Flow
$-2,605,375
Enterprise Value
$-25,433,146
Total Cash
$172,534,000
Total Debt
$20,685,000
Shares Out
11,182,597
Trailing EPS
$-3.70
Book Value
$17.33
ROE
-20.7%
ROA
-8.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 385,788,000 | -14,213,000 | -18,672,000 | 247,973,000 | 49,053,000 | 198,920,000 | 6,863,000 |
| Dec 2024 | 602,463,000 | 2,878,000 | 2,091,000 | 284,213,000 | 74,104,000 | 210,109,000 | 24,476,000 |
| Dec 2023 | 1,072,054,000 | 126,402,000 | 99,415,000 | 309,908,000 | 108,427,000 | 201,481,000 | 147,657,000 |
| Dec 2022 | 1,598,577,000 | 184,806,000 | 143,568,000 | 316,213,000 | 161,169,000 | 155,044,000 | 194,570,000 |
TTM Snapshot
Revenues TTM
$316,933,000
NetIncome TTM
$-25,602,000
OpCashFlow TTM
—
Assets (Latest)
$260,401,000
Forward EPS
$-0.04
Max Pain — expiry 2026-12-18
max pain strike: $10.00 · spot: $12.20 · call oi: 4,296 · put oi: 584
Expected Move to 2026-12-18:
±$1.02
(8.36%) —
implied range
$11.18 –
$13.22
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TWG | Top Wealth Group Holding Ltd | $132.86M | $2.23 | — |
| SUJA | SUJA LIFE, INC. | $155.58M | $6.54 | — |
| BRCC | BRC Inc. | $96.93M | $8.04 | — |
| WYHG | Wing Yip Food Holdings Group Ltd | $96.42M | $2.71 | — |
| SENEA | Seneca Foods Corp | $193.68M | $37.22 | — |
News headlines (Yahoo Finance, 1h cache)
Can Medifast's Coaching Model Complement GLP-1 Weight-Loss Drugs?
2026-11-18 16:39 · Yahoo
Will Medifast's Metabolic Health Institute Strengthen Its Edge?
2026-11-10 18:22 · Yahoo
Medifast: 3 Key Takeaways for Long-Term Investors
2026-11-03 20:20 · Yahoo
MED Q3 deep dive: new Trilogy brand and coach productivity drive evolving metabolic health strategy
2026-10-29 01:50 · Yahoo
5 insightful analyst questions from Medifast’s Q3 earnings call
2026-10-28 18:22 · Yahoo
Why Medifast (MED) stock is trading up today
2026-10-27 22:38 · Yahoo
Medifast (MED) Q3 Results Deepen Losses As Coach Decline Persists
2026-10-27 22:12 · Yahoo
Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises
2026-10-27 14:58 · Yahoo
Medifast (MED) Q3 2026 Earnings Call Transcript
2026-10-26 17:42 · Yahoo
Medifast, Inc. Q3 2026 Earnings Call Summary
2026-10-26 16:47 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.